Biotic and abiotic factors from soils have been implicated in the disease suppression of Rhizoctonia solani. This study included a Eucalyptus twig baiting assay, disease index and qPCR quantification of R. solani, and physicochemical analysis of 10 tobacco soils from five different locations (V: Vaqueros, C: Cerrillos, R: Rosario de Lerma, SA: San Agustín, CH: Chicoana) in the northwest of Argentina. Levels of Rhizoctonia soil inoculum quantified by baiting assay and qPCR were positively correlated. However, there was no correlation with root rot disease index in tobacco fields. Soils from V1, SA2 and CH2 fields, which reduced root rot disease on tobacco plants, were suppressive to R. solani infection. High clay, pH, organic matter content and physical stability in tobacco soils were the main physicochemical properties that limited Rhizoctonia development. Interestingly, growth of R. solani subgroups AG4‐HGI and AG4‐HGIII was highly suppressed in V1 and CH2 fields, and in SA2 fields, respectively. Undisturbed soil from a local forested mountain also resulted in reduction of growth of AG4‐HGIII and AG4‐HGI, while AG2‐1 was less affected, suggesting that high soil organic matter contributed to suppression of R. solani. Soils highly suppressive of R. solani had significantly different populations of culturable bacteria, Pseudomonas and fungi, but populations of actinobacteria and Trichoderma spp. did not differ. These different populations may be involved in the inhibition of fungal growth. The results demonstrated that physicochemical and biological properties of soil suppressive to R. solani could act as an alternative for controlling Rhizoctonia diseases on tobacco.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.